Global Cannabis Market 2022 - Industry Briefing

Global Cannabis Market 2022 - Industry Briefing

According to Gen Consulting Company, the global cannabis market is set to achieve an incremental growth of USD 25.3 billion, acelerating at a CAGR of almost 12.5% during the forecast period 2022-2028.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, compound type, application, and region. The global market data on cannabis can be segmented by product: capsules, concentrates, edibles, others. The concentrates segment was the largest contributor to the global cannabis market in 2021. Cannabis market is further segmented by compound type: balanced THC and CBD, cannabidiol (CBD), tetrahydrocannabinol (THC). According to the research, the THC segment had the largest share in the global cannabis market. Based on application, the cannabis market is segmented into: medical, recreational. The recreational segment held the largest revenue share in 2021. On the basis of region, the cannabis market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Globally, North America made up the largest share of the cannabis market.

The global cannabis market is highly competitive. Top players covered in Global Cannabis Market Study are Aphira Inc., Aurora Cannabis Inc., Cannimed Therapeutics Inc., Canopy Growth Corporation, CV sciences Inc., Delta 9 Cannabis Inc., GW Pharmaceuticals plc, Tilray Brands Inc., VIVO Cannabis Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Cannabis Market
• Identify segments/areas to invest in over the forecast period in the Global Cannabis Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.